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Purpose. To determine the presence and type of glaucoma in a cohort of adult Chinese subjects with systemic hypertension.Methods.
is prospective cohort study included 200 hypertensive Chinese adults aged >40 years old who underwent screening via frequency
doubling technology (FDT) perimetry and intraocular pressure (IOP) measurement by noncontact tonometry (NCT) in a general
outpatient clinic.ose with IOP > 21mmHg and/or visual �eld (VF) defects on FDTwere referred for complete ophthalmological
examination. e diagnosis of glaucoma was based on an abnormal VF on Humphrey Field Analyzer (HFA) by Hodapp-Parrish-
Anderson’s criteria and an increased vertical cup-disc ratio (VCDR). Results. e mean age of the subjects was 64.66 ± 9.47 years,
and the male:female ratio was 92 : 108. All patients were hypertensive with a mean blood pressure (BP) of 131.1 ± 15.1/76.6 ±
11.1mmHg whilst on systemic antihypertensive medication. Of the 111 patients that had an abnormal initial screening, 14 (7.9%)
were con�rmed to have glaucoma with the highest prevalence of normal tension glaucoma (NTG) (6.2%), followed by primary
angle closure glaucoma (PACG) (1.1%) and primary open angle glaucoma (POAG) (0.5%). e positive predictive value of FDT
perimetrywas 71%.Conclusion. Nearly 8% of the adults with systemic hypertension had glaucoma, andNTGwas themost prevalent
type.
1. Introduction
Glaucoma is a progressive optic neuropathy with characteris-
tic changes in the optic nerve head and corresponding visual
�eld loss. Currently, glaucoma accounts for 12% of all global
blindness with 4.5 million people aﬀected worldwide [1].
Primary open angle glaucoma (POAG) is more frequent in
Caucasian and African populations whilst primary angle clo-
sure glaucoma (PACG) is more common in Asian ethnicity.
Normal tension glaucoma (NTG) is especially prevalent in
Japan and Korea [2–4].
Raised intraocular pressure (IOP) remains the most
common and clinically modi�able risk factor. However,
glaucomatous optic neuropathy can occur despite normal
IOP as in NTG [5]. e role of vascular risk factors such as
systemic blood pressure (BP) and ocular perfusion pressure,
hypercoagulability, carotid artery disease, and vasospasm
have been extensively studied, and it has been shown that
abnormalities in systemic BP and ocular hypoperfusion are
vital in the pathogenesis of NTG [6–10].
Speculations about the association of glaucoma and sys-
temic hypertension still exist. Systemic hypertension has been
found to be associated with glaucoma but hypoperfusion has
been associated with the development and progression of
NTG [8, 11]. e purpose of this study is to determine the
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presence of glaucoma and type of glaucoma in Chinese adults
with systemic hypertension.
2. Subjects andMethods
Patients with systemic hypertension and older than 40 years
of age attending a regional general outpatient clinic were
recruited in the study. Ethics committee approval and
informed consent from subjects were obtained for this study.
Hypertension was de�ned as a presenting systolic BP ≥
140mmHg and/or diastolic BP ≥ 90mmHg without med-
ication. Patients were allowed to rest for 15 minutes before
checking BP via an automated digital machine (Dinamap Pro
100, Critikon, Tampa, United States of America). Patients
with BP > 160/100mmHg were rechecked.
e exclusion criteria consisted of those with central
nervous system disease that might aﬀect the perimetry result.
Patients underwent measurement of IOP with a non-
contact tonometry (Topcon Computerized Tonometer CT-
80A, Topcon Medical Systems, 111 Bauer Drive, Oakland,
NJ 07436, United States of America) and visual �eld assess-
ment using the FDT perimetry C-20-5 program (Carl Zeiss
Meditec, Dublin, CA, United States of America).
Patients with IOP > 21mmHg and/or visual �eld defects
on FDT were referred to an Ophthalmology Specialty Clinic
where they underwent a complete ophthalmic examination
includingmeasurements of best corrected Snellen visual acu-
ity, IOPmeasurement with Goldman applanation tonometry,
gonioscopy, anterior segment examination with slit lamp
biomicroscopy, detailed fundus examination including the
evaluation of vertical cup disc ratio (VCDR), visual �eld
examination with Humphrey Field Analyzer (HFA) using the
24-2 Swedish Interactive reshold Algorithm (SITA) (Carl
Zeiss Ophthalmic Systems, Inc, California, United States of
America), and central corneal thickness measurement with a
pachymeter echograph (Quantel Medical, 63039 Clermont-
Ferrand cedex 2, France).e presence of glaucomatous optic
neuropathy (GON) was established for those with abnormal
visual �eld defects on theHFA according toHodapp-Parrish-
Anderson’s criteria together with a corresponding enlarged
VCDR [12]. An elevation of IOP was not required for the
diagnosis of glaucoma.
e types of glaucoma were de�ned as
(1) normal tension glaucoma (NTG): GON plus IOP <
21mmHg and open angle,
(2) primary angle closure glaucoma (PACG): GON plus
≥ 270∘ peripheral anterior synechiae or appositional
closure less than grade 2 on gonioscopy according to
the Shaﬀer grading system,
(3) primary open angle glaucoma (POAG): GON with ≥
270∘ grade 2 or above on gonioscopy according to the
Shaﬀer grading system,
(4) Ocular hypertension (OHT): IOP > 21mmHg with-
out evidence of GON clinically and on HFA.
3. Results
Two hundred patients were included in this study. e mean
age was 64.66 ± 9.47 years (range 44–88 years). e male-
to-female ratio was 92 : 108. All patients were previously
diagnosed with hypertension and were started on antihyper-
tensive therapy; they had a mean BP of 131.1 ± 15.1/76.6 ±
11.1mmHg whilst on antihypertensive medication at the
time of the study.
Eighty-nine (44.5%) patients had normal IOP and FDT
on initial screening.Of the remaining 111 patients that had an
abnormal initial screening, 3 (1.5%) patients had an elevated
IOP > 21mmHg, 3 (1.5%) had both an elevated IOP and
abnormal FDT perimetry, and 105 patients (52.5%) had an
abnormal FDT perimetry only. All 111 patients were referred
to anOphthalmology Specialist Clinic for further assessment.
Of these, 2 had coexisting central nervous system disease
and therefore were excluded. Twenty patients were lost to
followup during the referral process. Of the remaining 89
patients, 14 patients had glaucomatous visual �eld defects
on HFA. irty-two subjects had nonspeci�c visual �eld
defects, and 16 had unreliable visual �elds despite repeated
investigations. In all, 14 (7.9%) patients were con�rmed to
have glaucoma. Of these, there was highest prevalence of
NTG (6.2%), followed by PACG (1.1%) and POAG (0.5%).
OHT (not requiring treatment) was found in 0.5%. ose
with nonspeci�c visual �eld defects were labeled as glaucoma
suspects and on subsequent examinations were diagnosed
to be normal (no glaucoma). A summary of participant
inclusion and results is shown in Figure 1, while a summary
of �nal results is presented in Figure 2.
e positive predictive value of FDT perimetry was 70%
whist the false positive rate was 22.2% with 7.8% of patients
unable to produce reliable visual �eld results.
4. Discussion
ere are controversies regarding the role of blood pressure
in glaucoma [13–21]. While some studies have indicated
that systemic hypertension is not associated with glaucoma
[13], others have shown associations between hypertension
and POAG and NTG [11, 14]. Even when a correlation
exists, some studies correlate systemic hypertension with an
increased risk for glaucoma, whilst others report a worsening
of glaucoma in those with low blood pressure [11]. Hyper-
tension seems to exert diﬀerent eﬀects on diﬀerent types of
glaucoma. Hypertension worsens POAG by the elevation of
IOP. For every 10mmHg elevation of systolic and diastolic BP
the IOP increases by 0.2–0.44mmHg and 0.4–0.85mmHg,
respectively [11]. For NTG, however, Wang et al. and Yanagi
et al. have shown that blood circulatory disorder plays a more
signi�cant role in the pathogenesis [13, 15].
Our study has shown that a substantial proportion
(7.9%) of systemic hypertensive Chinese subjects over 40
had glaucoma, with NTG being the most common (6.2%)
followed by PACG (1%) and POAG (0.5%). irty-two
percent of the hypertensive subjects had suspicious HFA
results and were followed up as glaucoma suspects for the
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Total number of patients recruited in the study = 200
NCT, FDT done for all patients
Normal = 89 Abnormal NCT FDT = 111
Referred to ophthalmologist
Number of patients underwent detailed
ophthalmologic exam = 89
Normal (no glaucoma) = 75 Glaucoma confirmed = 14
POAG= 1 PACG= 2 NTG = 11
Excluded = 22
(CNS diseases = 2; defaulted = 20)
+/−
F 1: Summary of subjects’ inclusion and results.
Total number of patients recruited in the study = 200
Normal (no glaucoma) = 164 (92.1%) Glaucoma confirmed = 14 (7.9%)
POAG= 1 (0.6%) PACG= 2 (1.1%) NTG = 11 (6.2%)
Excluded = 22
(CNS diseases = 2; defaulted = 20)
Number of patients included in
final analysis = 178
F 2: Summary of �nal results.
development of glaucoma. e presence of glaucoma in our
systemic hypertensive population in Hong Kong (7.9%) is
almost double the prevalence of glaucoma (3.8%) [22] in a
general population in Guangzhou, a Chinese province just
170 km away from Hong Kong. Furthermore, our prevalence
of PACG is identical (1%) in both populations [22]. On
the other hand, the presence of NTG is three times higher
than Guangzhou, 6.2% versus 1.8%, possibly signifying an
association between systemic hypertension and NTG [22].
e possible relationship between systemic hypertension
andNTG can be explained by the postulation that the glauco-
matous damage inNTG is caused by unstable perfusion of the
optic nerve. Autoregulation is a physiological phenomenon
whereby the vascular resistance changes dynamically to keep
the blood �ow at a constant level to uphold local metabolic
demands. Systemic hypertension exerts an oxidative stress to
the arterial wall which in addition to atherosclerosis can then
impair autoregulation such that an elevation of IOP above a
criteria level will comprise the ocular blood �ow and induce
optic nerve damage even though IOP may still be within
normal range [11]. Additionally, when hypertensive patients
are started on systemic antihypertensive medication, the
diurnal variation, postural hypotension, and nocturnal dips
induced by the systemic medication can further comprise
ocular perfusion pressure contributing to further optic nerve
hypoperfusion [17].
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FDT perimetry has been eﬀective for rapid detection of
early, moderate and advanced glaucomatous visual �eld loss
[23, 24]. It took approximately 4 to 5.5 minutes to perform
an FDT perimetry test using the C 20-5 test pattern. We
found that 70% of the subjects with abnormal FDT during
the initial screening process had suspicious abnormalities on
HFA. Since various factors can contribute to the variability
of response during perimetry such as fatigue and learning
curve, it is oen diﬃcult to diagnose early glaucomatous
visual �eld changes and may take serial perimetries in some
cases before de�nite glaucomatous visual �eld changes are
seen [25–31]. Although HFA is still the gold standard in
the diagnosis of glaucoma, our study has shown that FDT
perimetry may be used eﬀectively as a simple screening tool
in high risk populations and can be easily performed by
medical staﬀ without formal ophthalmological training, in a
general outpatient setting.
ere were certain limitations of our study. First, there
was no local control group for the presence of glaucoma
in nonhypertensive subjects. is was because the clinic at
which the patients underwent initial screening was a general
outpatient clinic which examined the patients with systemic
diseases, of which hypertensionwas one of themost common
systemic diseases. Nevertheless we used published data by
He et al. from a nearby locality as a basis of comparison
to determine the prevalence of glaucoma in the general
population [22]. Secondly, 20 out of 111 subjects who were
abnormal at initial screening were lost to followup during
the referral to the Ophthalmology Specialty centre as subjects
were required to pay for the additional investigations in
order to be fair to other patients who also require such
investigations but not belonging to the study. In addition,
although FDT does not have 100% sensitivity to detect
glaucoma in a population-based setting, it is likely that some
patients with glaucoma may have missed. But we understand
that since abnormal FDT and NCT were considered in
referring the patients for detailed investigation for presence
or absence of glaucoma, it is likely that majority of the
patients with glaucoma or suspected glaucoma were included
in the detailed examination. An additional fact that needs
a mention here is that the subjects with IOP > 21mmHg
were referred (even if they did not have VF defects). So
it is likely that we may have missed some patients with
lower IOP given the fact that we had a relatively higher
prevalence of normal tension glaucoma in our study. But
in order to explain this it would be important to consider
that IOP of 10–21mmHg is considered the normal range.
erefore during the screening procedure we considered
IOP of >21mmHg as cut-oﬀ point to refer the subjects
for detailed ophthalmological examination to determine the
presence/absence of glaucoma. is can be considered as
a bias in the referral of the patients. But given the fewer
number of patients with only IOP > 21mmHg as the
abnormal initial �nding, this would not havemade signi�cant
diﬀerence. In spite of these limitations, this preliminary
study has served its purpose in highlighting the presence of
glaucoma in a systemic hypertensive population. In order to
aﬃrm this correlation, a larger scale study involving both
nonhypertensive and hypertensive subjects is warranted.
In conclusion, nearly 8% of the systemic hypertensive
Chinese adults over 40 were found to have glaucoma with
NTG being the most prevalent, followed by PACG and
POAG.
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